Drugs / AS01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07527247 | Nov 2025 → Feb 2029 expected | — | Singapore General Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07527247 ↗ |
| Modality | Other / unclassified | “AS01 is a liposome-based adjuvant used in licensed vaccines” NCT07527247 ↗ |
| Route | Intramuscular | “AS01 adjuvant (0.5 mL intramuscular)” NCT07527247 ↗ |